Company Quick10K Filing
Newbridge Global Ventures
10-Q 2019-06-30 Filed 2019-10-15
10-Q 2019-03-31 Filed 2019-07-11
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-12-27
10-Q 2018-06-30 Filed 2018-08-14
S-1 2018-04-27 Public Filing
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-06
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-16
10-Q 2015-09-30 Filed 2015-11-20
10-K 2015-06-30 Filed 2015-09-30
10-Q 2015-03-31 Filed 2015-05-14
10-Q 2014-12-31 Filed 2015-02-12
10-Q 2014-09-30 Filed 2014-11-14
10-K 2014-06-30 Filed 2014-10-20
10-Q 2014-03-31 Filed 2014-05-20
10-Q 2013-12-31 Filed 2014-02-14
10-Q 2013-09-30 Filed 2013-11-14
10-K 2013-06-30 Filed 2013-10-15
10-Q 2013-03-31 Filed 2013-05-08
10-Q 2012-12-31 Filed 2013-02-22
10-Q 2012-09-30 Filed 2012-11-14
10-K 2012-06-30 Filed 2012-09-21
10-Q 2012-03-31 Filed 2012-05-16
10-Q 2011-12-31 Filed 2012-01-19
10-Q 2011-09-30 Filed 2011-10-14
10-K 2011-06-30 Filed 2011-07-22
10-Q 2011-03-31 Filed 2011-05-03
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-19
10-K 2010-06-30 Filed 2010-09-30
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-03
8-K 2020-09-30
8-K 2020-07-01
8-K 2020-03-10
8-K 2020-02-28
8-K 2019-12-09
8-K 2019-10-21
8-K 2019-10-18
8-K 2019-09-10
8-K 2019-09-03
8-K 2019-08-30
8-K 2019-08-28
8-K 2019-08-27
8-K 2019-06-26
8-K 2019-06-06
8-K 2019-05-13
8-K 2019-05-02
8-K 2019-05-01
8-K 2019-04-17
8-K 2019-04-16
8-K 2019-04-12
8-K 2019-02-21
8-K 2019-01-17
8-K 2019-01-15
8-K 2018-10-19
8-K 2018-10-05
8-K 2018-09-24
8-K 2018-09-14
8-K 2018-08-31
8-K 2018-07-26
8-K 2018-07-16
8-K 2018-07-12
8-K 2018-06-18
8-K 2018-05-08
8-K 2018-04-20
8-K 2018-03-05
8-K 2018-02-19
8-K 2018-02-06

Newbridge Global Ventures Financials

NBGV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Cash71028751253544168312521991,1336771044131,403931663246201,25790198
Accounts Receivable
Inventory
PP&E25333332313004,2195,4609,184
Assets4324146364011,7561,4711,3491,2711,244132161911324074791,3148561,6213,9144,2102,6682,62834712621414,63714,60022,306
Accounts Payable8375321671786210915715891152232121931109147264263283754384762257412,522
Long-Term Debt353327217341,875
Liabilities2082231813071,8621,7131,8962,1522,3783302491231261151653902882,5552,5992,0772,5501801151725451,8142,8549,397
Stockholders' Equity22419145694-107-241-547-881-1,134-198-2336762914631,2617661,3341,3591,61059079167-104-167-33112,82311,74612,364
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Revenue110190100
Cost of Revenue
Gross Profit
R&D
SG&A564053-3852511671754993291,655851801433971872295288119001,4278847542558375101,1642,7164,017
Tax00000000000
Net Income-48-34-53-520-256-926-345-578-399-2,177-85130-148-405-188-528-811-1,003-1,697-1,166-1,098-1,104-832-491-472-2,104-4,397
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-30
Cash Operating-22-20-53-450-48-87-24-23-54-70-222-86-187-132-246-488-924-1,812-685-1,470-750-31247-154-131-401
Cash Investing2223-262127222912900000-915
Cash Financing34017067640025-47290128653291,069361,706211-751561452,558